BC Diabetes Office

Vancouver V5Y 3W2

2 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 1

Studies at this site

• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) — Recruiting now